89Zr-IAB2M minibody imaging in patients with prostate cancer: Biodistribution, kinetics, lesion uptake and organ dosimetry

被引：0
|
作者：
Pandit-Taskar, Neeta [1 ]
Joseph, O. [1 ]
Lyashchenko, Serge [1 ]
Carrasquillo, Jorge [1 ]
Keppler, Jennifer [2 ]
Wu, Anna [2 ]
Weber, Wolfgang [1 ]
Scher, Howard [1 ]
Larson, Steven [1 ]
Morris, Michael [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] ImaginAb Inc, Los Angeles, CA USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2014年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1670
引用
收藏
页数：1
相关论文
共 50 条
  • [31] 89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
    Neeta Pandit-Taskar
    Joseph A. O’Donoghue
    Volkan Beylergil
    Serge Lyashchenko
    Shutian Ruan
    Stephen B. Solomon
    Jeremy C. Durack
    Jorge A. Carrasquillo
    Robert A. Lefkowitz
    Mithat Gonen
    Jason S. Lewis
    Jason P. Holland
    Sarah M. Cheal
    Victor E. Reuter
    Joseph R. Osborne
    Massimo F. Loda
    Peter M. Smith-Jones
    Wolfgang A. Weber
    Neil H. Bander
    Howard I. Scher
    Michael J. Morris
    Steven M. Larson
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 2093 - 2105
  • [32] CD8 PET IMAGING OF TUMOR INFILTRATING T CELLS IN ADVANCED SOLID TUMORS: A PHASE I FIRST-INHUMAN STUDY OF 89ZR-IAB22M2C, A RADIOLABELED ANTI-CD8 MINIBODY
    Farwell, Michael
    Gamache, Raymond
    Pandit-Taskar, Neeta
    Postow, Mike
    Gordon, Michael
    Wilson, Ian
    Mascioni, Alessandro
    Wu, Anna
    Le, William
    Weiss, Avital
    Korn, Ronald
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A179 - A180
  • [33] Pharmacokinetics and Biodistribution of a [89Zr]Zr-DFO-MSTP2109A Anti-STEAP1 Antibody in Metastatic Castration-Resistant Prostate Cancer Patients
    O'Donoghue, Joseph A.
    Danila, Daniel C.
    Pandit-Taskar, Neeta
    Beylergil, Volkan
    Cheal, Sarah M.
    Fleming, Stephen E.
    Fox, Josef J.
    Ruan, Shutian
    Zanzonico, Pat B.
    Ragupathi, Govind
    Lyashchenko, Serge K.
    Williams, Simon P.
    Scher, Howard I.
    Fine, Bernard M.
    Humm, John L.
    Larson, Steven M.
    Morris, Michael J.
    Carrasquillo, Jorge A.
    MOLECULAR PHARMACEUTICS, 2019, 16 (07) : 3083 - 3090
  • [34] In vivo dosimetry for prostate cancer patients using an electronic portal imaging device (EPID); demonstration of internal organ motion
    Kroonwijk, M
    Pasma, KL
    Quint, S
    Koper, PCM
    Visser, AG
    Heijmen, BJM
    RADIOTHERAPY AND ONCOLOGY, 1998, 49 (02) : 125 - 132
  • [35] Immuno-PET imaging of VEGFR-2 expression in prostate cancer with 89Zr-labeled ramucirumab
    Li, Miao
    Jiang, Dawei
    Barnhart, Todd E.
    Cao, Tianye
    Engle, Jonathan W.
    Chen, Weiyu
    Cai, Weibo
    AMERICAN JOURNAL OF CANCER RESEARCH, 2019, 9 (09): : 2037 - +
  • [36] HER-2-PET imaging with 89Zr-trastuzumab in metastatic breast cancer patients
    Munnink, T. Oude
    Dijkers, E.
    Hooge, M. Lub-de
    Kosterink, J.
    Brouwers, A.
    de Jong, J.
    van Dongen, G.
    de Vries, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [37] A COMPARISON OF 111IN-J591 SPECT WITH 89ZR-J591 PET IMAGING FOR PROSTATE CANCER PATIENTS
    Chalasani, Sandhya
    Fareedy, Shoaib
    Lindgren-Belal, Sarah
    Spratt, Daniel
    Robinson, Brian
    Osborne, Joseph
    Bander, Neil
    Scherr, Douglas
    JOURNAL OF UROLOGY, 2014, 191 (04): : E602 - E603
  • [38] Immuno-PET Imaging of the GFR-2 Expression in Prostate Cancer Using 89Zr labeled Ramucirumab
    Li, Miao
    Chen, Weiyu
    Jiang, Dawei
    Engle, Jonathan
    Cao, Tianye
    Cai, Weibo
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [39] [89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer
    Laforest, Richard
    Lapi, Suzanne E.
    Oyama, Reiko
    Bose, Ron
    Tabchy, Adel
    Marquez-Nostra, Bernadette V.
    Burkemper, Jennifer
    Wright, Brian D.
    Frye, Jennifer
    Frye, Sarah
    Siegel, Barry A.
    Dehdashti, Farrokh
    MOLECULAR IMAGING AND BIOLOGY, 2016, 18 (06) : 952 - 959
  • [40] [89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer
    Richard Laforest
    Suzanne E. Lapi
    Reiko Oyama
    Ron Bose
    Adel Tabchy
    Bernadette V. Marquez-Nostra
    Jennifer Burkemper
    Brian D. Wright
    Jennifer Frye
    Sarah Frye
    Barry A. Siegel
    Farrokh Dehdashti
    Molecular Imaging and Biology, 2016, 18 : 952 - 959
12345